ACEBROPHYLLINE 100mg. IP

A dual-action drug that acts as an airway mucus regulator and a bronchodilator. (Pozzi, 2007) Effective in lessening the frequency of episodes of bronchial obstruction. (Ajitha Sharma, 2014) Facilitates the muscles of the airways to relax and expel out mucus. (Ajitha Sharma, 2014) Possesses anti-inflammatory properties that help in clearing the inflammation of the lung airways. (Ajitha Sharma, 2014) Increases mucociliary clearance by augmenting ciliary motility in chronic obstructive pulmonary. (Sumit Roy Tapadar, 2014) Significantly decreases the amount of sputum and reduces airway obstruction. (Pozzi E. , 2007) Has the potential to limit the frequency of relapses of infection in bronchial obstruction. Lessens the need for beta2-agonists. (Gangajalia, 2019) More active than ambroxol as it reduces episodes of bronchospasm attack. (Dr. Kamlesh Kumar Pandey, 2019) A safer drug than theophylline in terms of cardiovascular and central nervous system-related side effects. (Dr. Kamlesh Kumar Pandey, 2019)